Application Nr Approved Date Route Status External Links
NDA203255 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Signifor Lar Is A Somatostatin Analog Indicated For The Treatment Of: Patients With Acromegaly Who Have Had An Inadequate Response To Surgery And/or For Whom Surgery Is Not An Option. ( 1.1 ) Patients With Cushing’s Disease For Whom Pituitary Surgery Is Not An Option Or Has Not Been Curative. ( 1.2 ) 1.1 Acromegaly Signifor Lar Is Indicated For The Treatment Of Patients With Acromegaly Who Have Had An Inadequate Response To Surgery And/or For Whom Surgery Is Not An Option. 1.2 Cushing’s Disease Signifor Lar Is Indicated For The Treatment Of Patients With Cushing’s Disease For Whom Pituitary Surgery Is Not An Option Or Has Not Been Curative.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pasireotide PASIREOTIDE ZINC169621234

Comments